Eurofins-Cerep SA
PAR:ALECR

Watchlist Manager
Eurofins-Cerep SA Logo
Eurofins-Cerep SA
PAR:ALECR
Watchlist
Price: 22 200 EUR 8.82% Market Closed
Market Cap: 111m EUR
Have any thoughts about
Eurofins-Cerep SA?
Write Note

Gross Margin
Eurofins-Cerep SA

85.6%
Current
76%
Average
43.8%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
85.6%
=
Gross Profit
39.5m
/
Revenue
46.2m

Gross Margin Across Competitors

Country FR
Market Cap 111.9m EUR
Gross Margin
86%
Country US
Market Cap 1.3T USD
Gross Margin
55%
Country US
Market Cap 196.3B USD
Gross Margin
41%
Country US
Market Cap 170.3B USD
Gross Margin
60%
Country KR
Market Cap 66.5T KRW
Gross Margin
50%
Country CH
Market Cap 37.6B CHF
Gross Margin
29%
Country US
Market Cap 38.5B USD
Gross Margin
55%
Country US
Market Cap 36.7B USD
Gross Margin
35%
Country US
Market Cap 26.4B USD
Gross Margin
59%
Country US
Market Cap 23B USD
Gross Margin
35%
Country US
Market Cap 22.3B USD
Gross Margin
64%
No Stocks Found

Eurofins-Cerep SA
Glance View

Market Cap
111.9m EUR
Industry
Life Sciences Tools & Services

Eurofins-Cerep SA engages in providing preclinical drug research services. The company is headquartered in Celle-Levescault, Nouvelle-Aquitaine and currently employs 211 full-time employees. The company went IPO on 2010-03-19. The Company, using its BioPrint technology systems that analyzes pharmaceutical drugs on the market, those that have been withdrawn, and those that failed in the development stages, builds up predictive models of the potential of new drugs. These predictions are based on the drugs' chemical structure and their performance in vitro. The firm then offers solutions to the pharmaceutical and biotechnology sectors on reducing time and costs in the early stages of the drug development process. Clients can also gain access to some of the Company's technology by subscribing to BioPrint. In December 2013, it sold Cerep Inc, its American subsidiary, to Eurofins-Panlabs Inc, part of the Eurofins Scientific SE group.

ALECR Intrinsic Value
20 976.22 EUR
Overvaluation 6%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
85.6%
=
Gross Profit
39.5m
/
Revenue
46.2m
What is the Gross Margin of Eurofins-Cerep SA?

Based on Eurofins-Cerep SA's most recent financial statements, the company has Gross Margin of 85.6%.